Your Taxes: Israeli firm wins Indian tax case

Was TTI’s income really royalty income resulting because of the copyright?

October 25, 2011 21:40
4 minute read.
New Israeli Shekels

Money Shekels bills 521. (photo credit: Courtesy)


Dear Reader,
As you can imagine, more people are reading The Jerusalem Post than ever before. Nevertheless, traditional business models are no longer sustainable and high-quality publications, like ours, are being forced to look for new ways to keep going. Unlike many other news organizations, we have not put up a paywall. We want to keep our journalism open and accessible and be able to keep providing you with news and analyses from the frontlines of Israel, the Middle East and the Jewish World.

As one of our loyal readers, we ask you to be our partner.

For $5 a month you will receive access to the following:

  • A user experience almost completely free of ads
  • Access to our Premium Section
  • Content from the award-winning Jerusalem Report and our monthly magazine to learn Hebrew - Ivrit
  • A brand new ePaper featuring the daily newspaper as it appears in print in Israel

Help us grow and continue telling Israel’s story to the world.

Thank you,

Ronit Hasin-Hochman, CEO, Jerusalem Post Group
Yaakov Katz, Editor-in-Chief


On August 26, an Israeli resident software company, TTI Team Telecom International Pvt., Ltd. (TTI) of Rosh Ha’ayin scored a victory in the Indian Income Tax Appellate Tribunal, Mumbai (E Bench, ITA No 3939/Mum/2010, Assessment Year 2006-07).

The facts

Be the first to know - Join our Facebook page.

TTI is an Israeli resident company that entered into an agreement with Reliance Infocomm for supply and license of software for RIL’s wireless network in India. Specifically, the agreement was a “perpetual, irrevocable, non-exclusive, royalty-free, worldwide license to install, use, operate or copy the software and the documentation licensed under the agreement solely for implementation, operation, management and maintenance of RIL’s Network within India.”

It was agreed that TTI did not have a permanent establishment (essentially, a fixed place of business) in India. This means TTI could not be taxed on business profits because it is an Israeli resident company not doing business in India.

But software is generally protected under copyright law. Was TTI’s income really royalty income resulting because of the copyright? The Indian assessing officer certainly thought so and claimed 10 percent royalty withholding tax from all such receipts under Article 12 of the India-Israel tax treaty.

TTI claimed the software receipts amounted to “business profits” derived outside India – and hence not taxable at all under the India- Israel tax treaty, rather than royalties.

The tribunal’s analysis


Article 12(3) of the India-Israel tax treaty, the term “royalties means “payments of any kind received as a consideration for the use of, or the right to use, any copyright of literary, artistic or scientific work including cinematograph films, any patent, trade mark, design or model, plan, secret formula or process, or for information concerning industrial, commercial or scientific experience.”

In this case, the tribunal discussed whether there is: (1) use of a copyright, or (2) use of a process? With regard to the first question (use of a copyright), the tribunal distinguished between “use of copyright” and “use of a copyrighted article.”

This is taken from US law, and in fact the tribunal was influenced by another case involving Motorola, (Motorola Inc. vs DCIT, 96 TTJ 1).

For example, when a person is using a music compact disc, that person is using the copyrighted article (i.e., the product itself) and not the copyright in that product.

To constitute “use of a copyright,” the transferee must enjoy four rights: (1) the right to make copies of the software for distribution to the public, (2) the right to prepare derivative computer programs based upon the copyrighted program, (3) the right to make a public performance of the computer program, and (4) the right to publicly display the computer program. If none of these rights are enjoyed by the purchaser, as in this case, there is no “use of a copyright.”

As for the second question (use of a process), the tribunal ruled that the consideration received by TTI is not for “use of a process,” because what the buyer is paying for is not for the “process” but for the “results” achieved by use of the software. In fact, under the standard terms and conditions for sale of the software, the buyer is not even allowed to tinker with the process on the basis of which such software runs, or even to work around the technical limitations of the software. It would be a “hyper-technical approach totally divorced from ground business realities” to hold that the use of software is use of a “process.”

The tribunal’s decision

The tribunal ruled that the software receipts were not royalties under the India-Israel tax treaty.

Instead, the receipts were business profits derived outside India. Therefore no Indian taxes applied to the software receipts in this case.


Israeli software firms and other hitech firms that export their products should always beware of business profit taxation and/or royalty withholding tax in each country concerned.

Royalty withholding tax is a tax on sales receipts even if the firm has tax losses in Israel (for example, from research and development).

Therefore, Israeli hi-tech firms should check carefully: (1) their contractual terms of business, (2) where and how they do business, and (3) local tax laws in each country.

In this case, a positive Indian precedent was set for Israeli software firms and firms from other countries that have a similar tax treaty with India. Nevertheless, Indian tax law and case decisions are constantly evolving and should be monitored.

As always, consult experienced tax advisers in each country at an early stage in specific cases. Leon Harris is a certified public accountant and tax specialist at Harris Consulting & Tax Ltd.

Join Jerusalem Post Premium Plus now for just $5 and upgrade your experience with an ads-free website and exclusive content. Click here>>

Related Content

The Teva Pharmaceutical Industries
April 30, 2015
Teva doubles down on Mylan, despite rejection